Previous close | 1.0100 |
Open | 1.2000 |
Bid | 1.1300 x 800 |
Ask | 1.1600 x 800 |
Day's range | 1.0700 - 1.2100 |
52-week range | 0.8000 - 2.1000 |
Volume | |
Avg. volume | 1,124,295 |
Market cap | 128.864M |
Beta (5Y monthly) | -0.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.3200 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.75 |
Key Insights Significantly high institutional ownership implies OptiNose's stock price is sensitive to their trading...
Gain Therapeutics (GANX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptiNose (OPTN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.